Segueix
UPötschger
UPötschger
Statistik
Correu electrònic verificat a ccri.at
Títol
Citada per
Citada per
Any
A randomized trial of treatment for multisystem Langerhans’ cell histiocytosis
H Gadner, N Grois, M Arico, V Broadbent, A Ceci, A Jakobson, D Komp, ...
The Journal of pediatrics 138 (5), 728-734, 2001
5822001
Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial
R Ladenstein, U Pötschger, MC Le Deley, J Whelan, M Paulussen, ...
J Clin Oncol 28 (20), 3284-3291, 2010
5812010
Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia
MN Dworzak, G Fröschl, D Printz, G Mann, U Pötschger, ...
Blood, The Journal of the American Society of Hematology 99 (6), 1952-1958, 2002
4542002
Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis
H Gadner, M Minkov, N Grois, U Pötschger, E Thiem, M Arico, ...
Blood, The Journal of the American Society of Hematology 121 (25), 5006-5014, 2013
4512013
Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease
T Lion, R Baumgartinger, F Watzinger, S Matthes-Martin, M Suda, ...
Blood 102 (3), 1114-1120, 2003
4282003
Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification
H Gadner, N Grois, U Pötschger, M Minkov, M Aricò, J Braier, V Broadbent, ...
Blood, The Journal of the American Society of Hematology 111 (5), 2556-2562, 2008
3762008
Risk factors for diabetes insipidus in langerhans cell histiocytosis
N Grois, U Pötschger, H Prosch, M Minkov, M Arico, J Braier, JI Henter, ...
Pediatric blood & cancer 46 (2), 228-233, 2006
3712006
Interleukin 2 with anti-GD2 antibody ch14. 18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial
R Ladenstein, U Pötschger, D Valteau-Couanet, R Luksch, V Castel, ...
The Lancet Oncology 19 (12), 1617-1629, 2018
3042018
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi …
R Ladenstein, U Pötschger, ADJ Pearson, P Brock, R Luksch, V Castel, ...
The lancet oncology 18 (4), 500-514, 2017
2912017
Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors …
C Peters, M Schrappe, A von Stackelberg, A Schrauder, P Bader, W Ebell, ...
Journal of clinical oncology: official journal of the American Society of …, 2015
2492015
Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation
T Lion, K Kosulin, C Landlinger, M Rauch, S Preuner, D Jugovic, ...
Leukemia 24 (4), 706-714, 2010
2132010
Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible
MN Dworzak, G Gaipa, R Ratei, M Veltroni, A Schumich, O Maglia, ...
Cytometry Part B: Clinical Cytometry: The Journal of the International …, 2008
2022008
Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study
C Peters, JH Dalle, F Locatelli, U Poetschger, P Sedlacek, J Buechner, ...
Journal of Clinical Oncology 39 (4), 295, 2021
1932021
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
J Vermeulen, K De Preter, A Naranjo, L Vercruysse, N Van Roy, ...
The lancet oncology 10 (7), 663-671, 2009
1922009
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy
MN Dworzak, A Schumich, D Printz, U Pötschger, Z Husak, A Attarbaschi, ...
Blood, The Journal of the American Society of Hematology 112 (10), 3982-3988, 2008
1912008
Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator
M Minkov, N Grois, A Heitger, U Pötschger, T Westermeier, H Gadner, ...
Medical and pediatric oncology 39 (6), 581-585, 2002
1822002
Langerhans cell histiocytosis in neonates
M Minkov, H Prosch, M Steiner, N Grois, U Pötschger, P Kaatsch, ...
Pediatric blood & cancer 45 (6), 802-807, 2005
1702005
Leucocyte transfusions from rhG‐CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
C Peters, M Minkov, S Matthes‐Martin, U Pötschger, V Witt, G Mann, ...
British journal of haematology 106 (3), 689-696, 1999
1671999
Persistence and reactivation of human adenoviruses in the gastrointestinal tract
K Kosulin, E Geiger, A Vécsei, WD Huber, M Rauch, E Brenner, F Wrba, ...
Clinical Microbiology and Infection 22 (4), 381. e1-381. e8, 2016
1542016
2′‐Chlorodeoxyadenosine (2‐CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH‐S‐98 protocol of the Histiocyte Society
S Weitzman, J Braier, J Donadieu, RM Egeler, N Grois, S Ladisch, ...
Pediatric blood & cancer 53 (7), 1271-1276, 2009
1512009
En aquests moments el sistema no pot dur a terme l'operació. Torneu-ho a provar més tard.
Articles 1–20